KUANGCHI (00439): Independent non-executive director, Mr. Huang Jijie, has been reappointed as a non-executive director.
Guangqi Science (00439) announced that Dr. Huang Jijie, the independent non-executive director of the company, has been reassigned as a non-executive director of the company, effective from December 9, 2025.
KUANGCHI (00439) announces that Dr. Huang Jijie, the independent non-executive director of the company, has been reappointed as a non-executive director, effective from December 9, 2025.
The Board of Directors of the company hereby announces that Dr. Wu Zhili, has resigned as an independent non-executive director, member of the audit committee, remuneration committee, and nomination committee respectively, in order to devote more time to developing his other businesses, effective from December 9, 2025.
Related Articles
Hangzhou Tigermed Consulting (03347) intends to repurchase the company's A-shares.
V&V TECH (08113) plans "2 for 1" rights issue
V&V TECH (08113) proposes to issue shares using a "2 for 1" benchmark, raising a maximum net amount of approximately HK$31.9 million.
Hangzhou Tigermed Consulting (03347) intends to repurchase the company's A-shares.
V&V TECH (08113) plans "2 for 1" rights issue
V&V TECH (08113) proposes to issue shares using a "2 for 1" benchmark, raising a maximum net amount of approximately HK$31.9 million.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
